GSK plc
GSK's GHG Emissions Data Preview
In 2024, GSK completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, GSK has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into GSK's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of GSK amounted to 755,000 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2023, the total operational greenhouse gas (GHG) emissions of GSK decreased by 8.04%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
GSK's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are GSK's Scope 1 emissions?
In 2024, the total Scope 1 emissions of GSK were 521,000 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has GSK reduced its Scope 1 emissions over time?
Since 2020, GSK's Scope 1 emissions have decreased by 26.72%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2023), GSK's Scope 1 emissions decreased by 10.33%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are GSK's Scope 2 emissions?
In 2024, GSK reported Scope 2 greenhouse gas (GHG) emissions of 44,000 tCOâ‚‚e using the market-based method, and 234,000 tCOâ‚‚e using the location-based method.
Has GSK reduced its Scope 2 emissions over time?
Since 2020, GSK's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 24.27%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2023), GSK's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that GSK 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does GSK use for Scope 2 reporting?
In 2024, GSK reported its Scope 2 emissions using the market-based method and using the location-based method.
GSK's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based